Avalue drives the precise upgrade of surgical robots
Summary
This collaboration aims to advance the future of surgery toward greater precision and efficiency, ultimately enhancing patient treatment outcomes. As the global medical robotics market continues to thrive, its estimated value reached USD 25.56 billion in 2023, with a projected compound annual growth rate (CAGR) of 16.55% from 2024 to 2030. In response to this trend, Avalue focuses on providing leading hardware technology to empower surgical robots, optimising workflows and enhancing postoperative care for patients. Its AI-powered robotic arm significantly improves positioning accuracy, overcoming the limitations of human dexterity, leading to better patient outcomes. This enables the application of machine vision technology to drive the robotic arm to the optimal position and use facial recognition for precise localisation and real-time tracking.